Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
Pharmaceutical Product Development, LLC (commonly known as PPD) is a leading global contract research organisation headquartered in the United States. Founded in 1985, PPD has established itself as a key player in the pharmaceutical and biotechnology industries, providing comprehensive drug development and lifecycle management services. With a strong presence in North America, Europe, and Asia, the company supports clients through innovative solutions tailored to their specific needs.
PPD's core offerings include clinical development, laboratory services, and consulting, all designed to accelerate the delivery of new therapies to market. Renowned for its commitment to quality and efficiency, PPD has achieved significant milestones, including numerous successful product launches and partnerships with major pharmaceutical companies. As a trusted partner in the drug development process, PPD continues to enhance its market position through a focus on scientific excellence and operational agility.
+61 vs industry average
Pharmaceutical Product Development, LLC’s score of 93 is higher than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Research Services has below-average carbon intensity
The Research Services industry has reduced its overall emissions by 19% since 2018
No reported emissions data is available for Pharmaceutical Product Development, LLC yet.
Pharmaceutical Product Development, LLC, headquartered in the US, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Thermo Fisher Scientific Inc., and any climate commitments or emissions data would be cascaded from this parent organisation.
As part of its corporate family, Pharmaceutical Product Development, LLC aligns with the sustainability initiatives and targets set by Thermo Fisher Scientific Inc. This includes participation in various climate-related initiatives, although specific reduction targets or achievements for Pharmaceutical Product Development, LLC itself have not been disclosed.
The absence of direct emissions data highlights the importance of understanding the broader context of climate commitments within the pharmaceutical industry. Companies like Thermo Fisher Scientific Inc. often set ambitious targets to reduce their carbon footprint, which may indirectly influence their subsidiaries.
In summary, while specific emissions data for Pharmaceutical Product Development, LLC is not available, the company is part of a larger corporate structure that is committed to sustainability and climate action through its parent organisation, Thermo Fisher Scientific Inc.
Access structured emission data, company specific factors and auditable source documents
No climate goals have been disclosed for Pharmaceutical Product Development, LLC yet.
No scope 3 category breakdown has been disclosed yet.


You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more